Table 1.
Demographics features of pediatric patients with COVID-19
| Parameters | Total | Asymptomatic | Mild | Moderate | Critical/severe | p |
|---|---|---|---|---|---|---|
| n=190 | n=11 | n=139 | n=35 | n=5 | ||
| Age, months (median, min-max) | 72 (2–216) | 93 (14–216) | 69 (2–305) | 84 (4–237) | 42 (7–165) | 0.883 |
| Age group, years, n (%) | ||||||
| <1 | 21 (11.1) | 0 (0) | 14 (10.1) | 6 (17.1) | 1 (20.0) | 0.494 |
| 1–5 | 63 (33.2) | 3 (27.3) | 49 (35.3) | 9 (25.7) | 2 (40.0) | |
| 6–10 | 42 (22.1) | 5 (45.5) | 28 (20.1) | 9 (25.7) | 0 (0) | |
| 11–15 | 34 (17.9) | 2 (18.2) | 26 (18.7) | 4 (11.4) | 2 40.0) | |
| >15 | 28 (14.7) | 1 (9.1) | 21 (15.1) | 6 (17.1) | 0 (0) | |
| Sex, n (%) | ||||||
| Male | 88 (46.3) | 5 (45.5) | 60 (43.2) | 20 (57.1) | 3 (60.0) | 0.460 |
| Female | 102 (53.7) | 6 (54.5) | 79 (56.8) | 15 (42.9) | 2 (40.0) | |
| Smoking at home, n (%) | 93 (48.9) | 5 (45.5) | 66 (47.5) | 19 (64.3) | 3 (60.0) | 0.197 |
| BCG vaccination, n (%) | 168 (88.4) | 9 (81.8) | 125 (89.9) | 29 (82.9) | 5 (100) | 0.477 |
| Family history/close contact, n (%) | 115 (60.5) | 10 (90.9) | 87 (62.6) | 14 (40.0) | 4 (80.0) | 0.009 |
| Underlying disease, n (%) | 24 (12.6) | 2 (18.2) | 10 (7.2) | 7 (20) | 2 (40.0) | 0.079 |
| Chronic drug use, n (%) | 19 (10) | 0 (0) | 13 (6.7) | 7 (20) | 2 (40.0) | 0.010 |
| Length of stay (days), median (IQR) | 7 (5–9.25) | 4 (3–5) | 6 (4–8) | 8.5 (7–11) | 12 (8–20.5) | <0.001 |
| Ambulatory, n (%) | 72 (37.9) | 9 (81.8) | 61 (43.9) | 2 (5.7) | 0 (0) | <0.001 |
| Hospitalized n (%) | 113 (59.5) | 2 (18.2) | 77 (55.4) | 30 (85.7) | 4 (80.0) | |
| PICU n (%) | 5 (2.6) | 0 (0) | 1 (0.7) | 3 (8.6) | 1 (20.0) |
IQR: Interquartile range, BCG: Bacillus Calmette-Guerin, PICU: Pediatric intensive care unit.